Recent developments in interferon-based therapies for multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent developments in interferon-based therapies for multiple sclerosis

Published:2018-04-20 Issue:6 Volume:18 Page:665-680
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Dumitrescu Laura¹²,Constantinescu Cris S.³,Tanasescu Radu¹²³

Affiliation:

1. Department of Clinical Neurosciences, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

2. Department of Neurology, Colentina Hospital, Bucharest, Romania

3. Academic Clinical Neurology, Division of Clinical Neuroscience, University of Nottingham, UK

Funder

This paper is not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1462793

Reference164 articles.

1. Defining the clinical course of multiple sclerosis: The 2013 revisions

2. Defining the clinical course of multiple sclerosis: Results of an international survey

3. Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies

4. Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients;Multiple Sclerosis and Related Disorders;2024-06

2. Long-Term Disability Outcomes in Relapsing–Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression;Journal of Clinical Medicine;2024-03-21

3. Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients;2023-11-10

4. The evolution of interferon therapy in multiple sclerosis;Neurology, Neuropsychiatry, Psychosomatics;2023-08-21

5. Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID;International Journal of Molecular Sciences;2022-11-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3